LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
Agilent Technologies
Agilent Technologies
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services and consumables address the full range of scientific and laboratory management needs.
Tags
Sample prep
LinkedIn Logo

Systematic Evaluation of ChIP-seq Conditions with Automation

RECORD | Already taken place Th, 8.6.2023
Here, we automated this single-pot ChIP-seq protocol end-to-end using the Agilent Bravo.
Go to the webinar
Agilent Technologies: Systematic Evaluation of ChIP-seq Conditions with Automation
Agilent Technologies: Systematic Evaluation of ChIP-seq Conditions with Automation

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is a well-established method for studying the genomic localization of DNA-associated proteins. ChIP-seq is widely used to study DNA-associated proteins such as histone modifications, chromatin regulators, and transcription factors. While ChIP-seq is highly useful, the overall experimental workflow involves multiple steps that increase the risk of introducing inconsistency within experiments and between groups. Recently, we developed a single-pot ChIP-seq with on-bead library preparation. This protocol enables generation of sequencing libraries from low cell numbers and also reduces the costs (~$60 per sample, including Illumina library preparation), enabling to scale up the number of conditions. (Texari et al., STARS Protocols, 2021).

Here, we automated this single-pot ChIP-seq protocol end-to-end using the Agilent Bravo. Our automated process is scalable - conducting between 8-96 ChIP-seq reactions . We benchmarked the automated protocol by performing manual ChIP-seq reactions in parallel and demonstrated a high reproducibility and nearly indistinguishable signal-to-noise ratio between manual and automated workflows. As a proof of principle, we used our automated ChIP-seq protocol to evaluate multiple parameters and identify optimal conditions, including shearing and crosslinking conditions, buffer compositions, and antibody ratios. Our automated ChIP-seq protocol will be publicly available and will include specific deck setups as well as software files and parameters. Lastly, we envision that our robust protocol can advance research by enabling core facilities to provide ChIP-seq as a service and can potentially be incorporated into compound screening and diagnostic frameworks.

Presenter: Alon Goren, PhD (Associate Professor, Department of Medicine, University of California San Diego)

Agilent Technologies
LinkedIn Logo
 

Related content

Overcoming Strong Solvent Effects in the Analysis of Vepdegestrant

Applications
| 2026 | Agilent Technologies
Instrumentation
HPLC
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Identification of Double Bond Positions and Relative Acyl Chain Positions in Egg Yolk Phosphatidylcholines Using OAD-TOF System

Applications
| 2026 | Shimadzu
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Shimadzu
Industries
Food & Agriculture

High Molecular-Weight Polysaccharide Characterization by SEC-MALS Using GTxResolve™ 1000 and 2000 Å SEC Columns

Applications
| 2026 | Waters
Instrumentation
GPC/SEC, Consumables, LC columns
Manufacturer
Waters
Industries
Pharma & Biopharma, Food & Agriculture

Development and Optimization for a Comprehensive LC/MS/MS Method for the Detection of 74 PFAS Compounds

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Food & Agriculture

PFAS in Biota: Risk Context & Robust Analytical Solutions

Others
| 2026 | ALS Europe
Instrumentation
Laboratory analysis, LC/MS, LC/MS/MS
Manufacturer
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike